Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Basilea Pharmaceutica"
Count: 67
Selected: 0
NCT IDTitle
NCT02895360Phase 1/2a Study of BAL101553 as 48-hour Infusions in Patients With Advanced Solid Tumors or Recurrent Glioblastoma
NCT04604132Derazantinib Alone or in Combination With Paclitaxel, Ramucirumab or Atezolizumab in Gastric Adenocarcinoma
NCT03138733Ceftobiprole in the Treatment of Patients With Staphylococcus Aureus Bacteremia
NCT03230318Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma
NCT04045613Derazantinib and Atezolizumab in Patients With Urothelial Cancer
NCT02490800Phase 1/2a Study of Oral BAL101553 in Adult Patients With Solid Tumors or Glioblastoma or High-grade Glioma
NCT04087876Expanded Access Use of Derazantinib for Advanced Intrahepatic Cholangiocarcinoma (iCCA) With FGFR Genomic Alterations
NCT04098692Mass Balance and Pharmacokinetics Study of Derazantinib in Healthy Male Subjects
NCT02527681Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antibiotics
NCT03137173Ceftobiprole in the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infections
NCT03439124Ceftobiprole in the Treatment of Pediatric Patients With Pneumonia
NCT03250299Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
NCT01397929An Open-Label Study of Intravenous BAL101553 in Adult Patients With Solid Tumors
NCT01752920Phase 1/2 Study of Derazantinib (ARQ 087) in Adult Subjects With Advanced Solid Tumors With FGFR Genetic Alterations
NCT00413439Safety, Efficacy and Pharmacokinetics of an Antifungal in Patients Undergoing Chemotherapy
NCT00505258Ceftobiprole in the Treatment of Hospitalized Patients With Staphylococcus Aureus Bacteremia
NCT00229008Ceftobiprole in Hospital Acquired Pneumonia
NCT00210964Ceftobiprole in Hospital Acquired Pneumonia
NCT01030731Pharmacokinetic Study,Ceftobiprole,Healthy Volunteers,Healthy Patients With End Stage Renal Disease
NCT01026558A Study Evaluating the Pharmacokinetics of Ceftobiprole When Taken by Obese Patients
NCT00326287Ceftobiprole in the Treatment of Patients With Community-Acquired Pneumonia
NCT00529282A Study of Ceftobiprole in Patients With Fever and Neutropenia.
NCT01026740Evaluation of Penetration of Ceftobiprole Into Soft Tissue Determined by Microdialysis in Healthy Volunteers
NCT00965042Effect of Ceftobiprole on Human Intestinal Microflora
NCT00771719Open Label Pharmacokinetic in Adult Patients With Ventilator-Associated Pneumonia
NCT00771524Pharmacokinetic Study of the Penetration of Ceftobiprole in the Bone
NCT00770978Open Label Study of Ceftobiprole to Evaluate Pharmacokinetics in Adults Hospitalized in the ICU
NCT01026636A Single-Dose Pharmacokinetics and Safety Study of Ceftobiprole in Pediatric Patients =3 Months to <18 Years of Age
NCT00228982Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections
NCT00210899Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections
NCT00519675Alitretinoin in the Treatment of Chronic Hand Eczema
NCT00309621Safety and Efficacy of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis
NCT00124475Efficacy and Safety of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis
NCT00124436Follow-up Efficacy and Safety of Alitretinoin in Severe Chronic Hand Dermatitis
NCT00817063Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
NCT00413218Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
NCT01245140Efficacy of Alitretinoin Treatment in Patients With Pustular Form of Psoriasis
NCT01406171Drug Interaction Study of Isavuconazole and Midazolam
NCT03241550A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients
NCT00412893Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
NCT00634049Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
NCT01407679Efficacy and Safety of Oral Alitretinoin (Toctino®) in the Treatment of Patients With Cutaneous Lupus Erythematosus
NCT01657890Study of the Pharmacokinetics of Isavuconazole in Healthy Non-Elderly and Elderly Male and Female Subjects
NCT01657838Drug Interaction Study of the Effect of Ketoconazole at Steady State on the Pharmacokinetics of a Single Dose of Isavuconazole in Healthy Adult Subjects
NCT01635972Drug Interaction Study of Multiple Doses of Isavuconazole and a Single Dose of Bupropion
NCT01582412Drug Interaction Study of Isavuconazole and Digoxin
NCT01555866Study of the Effect of Renal Impairment on the Pharmacokinetics of Isavuconazole.
NCT01660477Drug-drug Interaction Study Between Lopinavir/Ritonavir and Isavuconazole
NCT01651325Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Dextromethorphan in Healthy Adult Subjects
NCT01635946Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Atorvastatin